RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 60, Issue 4, 1985, Pages 692-697

  Bardon, Sylvie ^a   Vignon, Françoise ^a   Chalbos, Dany ^a   Rochefort, Henri ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; DEXAMETHASONE; ESTRADIOL; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR;

BREAST; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; DOSE TIME EFFECT RELATION; DRUG COMPARISON; DRUG RECEPTOR BINDING; HUMAN; IN VITRO STUDY; PHARMACOKINETICS; PRIORITY JOURNAL; THERAPY;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTRENES; GLUCOCORTICOIDS; HUMAN; MIFEPRISTONE; NEOPLASM PROTEINS; PROGESTATIONAL HORMONES; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; SUPPORT, NON-U.S. GOV'T;

EID: 0021941831     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-60-4-692     Document Type: Article

References (32)

1. Lippman ME, Bolan G, Huff K 1976 The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long term tissue culture. Cancer Res 36:4595
2. Rochefort H, Bardon S, Chalbos D, Vignon F 1984 Steroidal and non steroidal antiestrogens in breast cancer cells in culture. J Steroid Biochem 20:105
3. Miller MA, Katzenellenbogen BS 1983 Characterization and quantitation of antiestrogen binding sites in estrogen receptor positive and negative human breast cancer cell lines. Cancer Res 23:3094
4. Vignon F, Bardon S, Chalbos D, Rochefort H 1983 Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. J Clin Endocrinol Metab 56:1124
5. Rochefort H, Garcia M 1984 The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther, 23:193
6. Horwitz KB, Mockus MB, Lessey BA 1982 Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell 28:633
7. Mockus MB, Horwitz KB 1983 Progesterone receptors in human breast cancer: stoichiometric translocation and nuclear receptor processing. J Biol Chem 258:4778
8. Philibert D, Deraedt R, Teutsch G, RU38486, a potent antiglucocorticoid in vivo. VIII International Congress of Pharmacology, Tokyo, Japan, 1981 (Abstract 1463)
9. Philibert D, Deraedt R, Teutsch G, Tourneminen C, Sakiz E, RU38486, a new lead for steroidal anti-hormones. Program of the 64th Annual Meeting of The Endocrine Society, San Francisco, CA, 1982 (Abstract 668)
10. Chobert MN, Barouki R, Finidori J, Aggerbeck M, Hanoune J, Philibert D, Deraedt R 1983 Antiglucocorticoid properties of RU38486 in a differentiated hepatoma cell line. Biochem Pharmacol 32:3481
11. Herrmann W, Wyss R, Riodel A, Philibert D, Teutsch G, Sakiz E, Baulieu EE 1982 Effet d’un stéroide antiprogestérone chez la femme: interruption du cycle menstruel et de la grossesse au début. C R Seances Acad Sci [III] 294:933
12. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ 1979 Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15:659
13. Soule HD, Vazquez J, Lang A, Albert S, Brennan MA 1973 A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409
14. Lasfargues EY, Ozzello L 1958 Cultivation of human breast carcinomas. J Natl Cancer Inst 21:1131
15. Cailleau R, Young R, Olive M, Reeves WJ 1974 Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661
16. De Larco JE, Todaro G 1978 Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J Cell Physiol 94:335
17. Vignon F, Terqui M, Westley B, Derocq D, Rochefort H 1980 Effect of plasma estrogen sulfate in mammary cancer cells. Endocrinology 106:1079
18. Kissane JM, Robins E 1958 The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 233:184
19. O’Farrell PH 1975 High resolution two-dimensional electrophoresis proteins. J Biol Chem 10:4007
20. Chalbos D, Rochefort H 1984 A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47D. Biochem Biophys Res Commun 121:421
21. Westley B, Rochefort H 1980 A secreted glycoprotein induced by estrogen in human breast cancer cell line. Cell 20:353
22. Chalbos D, Vignon F, Keydar I, Rochefort H 1982 Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab 55:276
23. Horwitz KB, Koseki Y, McGuire WL 1978 Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103:1742
24. Ruhmann AG, Berliner DL 1965 Effect of steroids on growth of mouse fibroblasts in vitro. Endocrinology 76:916
25. Jung-Testas I, Baulieu EE 1983 Inhibition of glucocorticoid action in cultured L-929 mouse fibroblasts by RU486, a new anti-gluco-corticosteroid of high affinity for the glucocorticosteroid receptor. Exp Cell Res 147:177
26. Chalbos D, Rochefort H 1984 Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells. J Biol Chem 259:1231
27. Moguilewsky M, Philibert D 1984 RU38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J Steroid Biochem 20:271
28. Horwitz KB 1983 Progestins, antiprogestins and progesterone receptors in breast cancer: mechanisms and biological actions. J Steroid Biochem 19:1065 (Abstract)
29. Rochefort H, Borgna JL 1981 Differences between oestrogen receptor activation by oestrogen and antioestrogen. Nature 292:257
30. Bardon S, Vignon F, Derocq D, Rochefort H 1984 The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor. Mol Cell Endocrinol 35:89
31. Vignon F, Derocq D, Chambon M, Rochefort H 1983 Les protéines oestrogéno-induites sécrétées par les cellules mammaires cancéreuses humaines MCF7 stimulent leur prolifération. C R Seances Acad Sci [III] 296:151
32. Gaillard RC, Riondel A, Muller AF, Herrmann W, Baulieu EE 1984 RU486: A steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 81:3879